{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:55:35Z","timestamp":1773665735823,"version":"3.50.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1093\/jac\/43.1.95","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:35:13Z","timestamp":1027722913000},"page":"95-103","source":"Crossref","is-referenced-by-count":25,"title":["Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics"],"prefix":"10.1093","volume":"43","author":[{"given":"Andreas H.","family":"Groll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corina E.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neelam","family":"Giri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krystina","family":"Kligys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Love","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erwin","family":"Feuerstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Bacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Piscitelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,1]]},"reference":[{"key":"key\n\t\t\t\t20170411035151_R1","doi-asserted-by":"crossref","unstructured":"Anaissie, E. 1992 Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clinical Infectious Diseases 14, Suppl. 1, 43\u201353.","DOI":"10.1093\/clinids\/14.Supplement_1.S43"},{"key":"key\n\t\t\t\t20170411035151_R2","doi-asserted-by":"crossref","unstructured":"Pannuti, C. S., Gingrich, R. D., Pfaller, M. A. & Wenzel, R. P. 1991 Nosocomial pneumonia in adult patients undergoing bone marrow transplantation: a 9-year study. Journal of Clinical Oncology 9, 77\u201384.","DOI":"10.1200\/JCO.1991.9.1.77"},{"key":"key\n\t\t\t\t20170411035151_R3","doi-asserted-by":"crossref","unstructured":"Weinberger, M., Elattar, I., Marshall, D., Steinberg, S. M., Redner, R. L., Young, N. S. et al.1992 Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as major cause of death. Medicine 71, 24\u201343.","DOI":"10.1097\/00005792-199201000-00003"},{"key":"key\n\t\t\t\t20170411035151_R4","doi-asserted-by":"crossref","unstructured":"Groll, A. H., Shah, P. M., Mentzel, C., Schneider, M., Just- Nuebling, G. & Huebner, K.1996 Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. Journal of Infection 33, 23\u201332.","DOI":"10.1016\/S0163-4453(96)92700-0"},{"key":"key\n\t\t\t\t20170411035151_R5","doi-asserted-by":"crossref","unstructured":"Denning, D. W. 1996 Therapeutic outcome in invasive aspergillosis. Clinical Infectious Diseases 23, 608\u201315.","DOI":"10.1093\/clinids\/23.3.608"},{"key":"key\n\t\t\t\t20170411035151_R6","doi-asserted-by":"crossref","unstructured":"Hiemenz, J. W. & Walsh, T. J. 1996 Lipid formulations of amphotericin B: recent progress and future directions. Clinical Infectious Diseases 22, Suppl. 2, S133\u201344.","DOI":"10.1093\/clinids\/22.Supplement_2.S133"},{"key":"key\n\t\t\t\t20170411035151_R7","unstructured":"Hazen, E. L. & Brown, R. 1950 Two antifungal agents produced by a soil actinomycete. Science 112, 423."},{"key":"key\n\t\t\t\t20170411035151_R8","unstructured":"Hamilton-Miller, J. M. T. 1973 Chemistry and biology of the polyene macrolide antibiotics. Bacteriological Reviews 37, 166\u201396."},{"key":"key\n\t\t\t\t20170411035151_R9","doi-asserted-by":"crossref","unstructured":"Mehta, R. T., Hopfer, R. L., Gunner, L. A., Juliano, R. L. & Lopez-Berestein, G. 1987 Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis. Antimicrobial Agents and Chemotherapy31 , 1897\u2013900.","DOI":"10.1128\/AAC.31.12.1897"},{"key":"key\n\t\t\t\t20170411035151_R10","doi-asserted-by":"crossref","unstructured":"Mehta, R. T., Hopfer, R. L., McQueen, T., Juliano, R. L. & Lopez-Berestein, G. 1987 Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections. Antimicrobial Agents and Chemotherapy 31, 1901\u20133.","DOI":"10.1128\/AAC.31.12.1901"},{"key":"key\n\t\t\t\t20170411035151_R11","unstructured":"Wallace, T. L., Paetznick, V., Cossum, P. A., Lopez-Berestein, G., Rex, J. H. & Anaissie, E.1997 Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. Antimicrobial Agents and Chemotherapy 41,2238\u2013 43."},{"key":"key\n\t\t\t\t20170411035151_R12","unstructured":"Boutati, E., Maltezou, H. C., Lopez-Berestein, G., Vartivarian, S. E. & Anaissie, E. (1995). Phase I study of maximum tolerated dose of intravenous liposomal nystatin for the treatment of refractory febrile neutropenia in patients with haematological malignancies. In Program and Abstracts of the Thirty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract LM 22, p. 330. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411035151_R13","unstructured":"Committee on the Care and Use of Laboratory Animals of the Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. (1996). Guide for the Care and Use of Laboratory Animals. National Academy Press, Washington, DC."},{"key":"key\n\t\t\t\t20170411035151_R14","unstructured":"Walsh, T. J., Bacher, P. & Pizzo, P. A. 1988 Chronic silastic central venous catheterization for induction, maintenance, and support of persistent granulocytopenia in rabbits. Laboratory Animal Science 38, 467\u201371."},{"key":"key\n\t\t\t\t20170411035151_R15","unstructured":"Vaughan, V. C. & Litt, I. F. (1992). Growth and Development. In Textbook of Pediatrics , 14th edn (Behrman, R. E., Kliegman, R. M., Nelson, W. E. & Vaughan, V. C., Eds), p. 40. W. B. Saunders, Philadelphia, PA."},{"key":"key\n\t\t\t\t20170411035151_R16","doi-asserted-by":"crossref","unstructured":"Espinel-Ingroff, A., Dawson, K., Pfaller, M., Anaissie, E., Breslin, E., Dixon, D. et al.1995 Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi. Antimicrobial Agents and Chemotherapy 39,314\u2013 9.","DOI":"10.1128\/AAC.39.2.314"},{"key":"key\n\t\t\t\t20170411035151_R17","unstructured":"Walsh, T. J., McEntee, C. & Dixon, D. M. 1987 Tissue homogenization with sterile reinforced polyethylene bags for quantitative culture of Candida albicans.Journal of Clinical Microbiology 25, 931\u20132."},{"key":"key\n\t\t\t\t20170411035151_R18","doi-asserted-by":"crossref","unstructured":"Walsh, T. J., Garrett, K., Feuerstein, E., Girton, M., Allende, M., Bacher, J. et al.1995 Therapeutic monitoring of experimental invasive pulmonary aspergillosis by ultrafast computerized tomography, a novel, noninvasive method for measuring responses to antifungal therapy. Antimicrobial Agents and Chemotherapy 39, 1065\u20139.","DOI":"10.1128\/AAC.39.5.1065"},{"key":"key\n\t\t\t\t20170411035151_R19","doi-asserted-by":"crossref","unstructured":"Shah, V. P., Midha, K. K., Dighe, S., McGilveray, I. J., Skelly, J. P., Yacobi, A. et al.1991 Analytical methods validation: bioavailability, bioequivalence and pharmacokinetic studies. European Journal of Drug Metabolism and Pharmacokinetics 16, 249\u201355.","DOI":"10.1007\/BF03189968"},{"key":"key\n\t\t\t\t20170411035151_R20","unstructured":"Gibaldi, M. & Perrier, D. (1982). Pharmacokinetics , 2nd edn. Marcel Dekker, Inc., New York."},{"key":"key\n\t\t\t\t20170411035151_R21","unstructured":"Schneider, M. (1985). Liposomes as drug carriers: 10 years of research. In Drug Targeting (Buri, P. & Gumma, A., Eds), pp. 119\u201334. Elsevier Science Publishers, New York."},{"key":"key\n\t\t\t\t20170411035151_R22","doi-asserted-by":"crossref","unstructured":"Rios, A., Rosenblum, M., Crofoot, G., Lenk, R. P., Hayman, A. & Lopez-Berestein, G.1993 Pharmacokinetics of liposomal nystatin in patients with human immunodeficiency virus infection. Journal of Infectious Diseases168, 253\u20134.","DOI":"10.1093\/infdis\/168.1.253"},{"key":"key\n\t\t\t\t20170411035151_R23","unstructured":"Cossum, P. A., Wyse, J., Simmons, Y., Wallace, T. L. & Rios, A. (1996). Pharmacokinetics of Nyotran (liposomal nystatin) in human patients. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract A88, p. 17. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411035151_R24","unstructured":"Jessup, C. J., Wallace, T. L. & Ghannoum, M. A. (1997). Evaluation of antifungal activity of Nyotran against various pathogenic fungi. In Program and Abstracts of the Thirty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1997. Abstract F88, p. 161. American Society for Microbiology, Washington, DC."},{"key":"key\n\t\t\t\t20170411035151_R25","unstructured":"Johnson, E. M., Ojwang, J. O., Szekely, A., Wallace, T. L. & Warnock, D. W. 1998 Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations. Antimicrobial Agents and Chemotherapy 42,1412\u2013 6."},{"key":"key\n\t\t\t\t20170411035151_R26","doi-asserted-by":"crossref","unstructured":"Ellner, P. D. & Neu, H. C. 1981 The inhibitory quotient. A method for interpreting minimum inhibitory concentration data. Journal of the American Medical Association246, 1575\u20138.","DOI":"10.1001\/jama.1981.03320140063033"},{"key":"key\n\t\t\t\t20170411035151_R27","doi-asserted-by":"crossref","unstructured":"Honeybourne, D. & Baldwin, D. R. 1992The site concentrations of antimicrobial agents in the lung. Journal of Antimicrobial Chemotherapy 30, 249\u201360.","DOI":"10.1093\/jac\/30.3.249"},{"key":"key\n\t\t\t\t20170411035151_R28","doi-asserted-by":"crossref","unstructured":"Kinsky, S. C., Avruch, J., Permutt, M. & Rogers, H. B. 1962 The lytic effect of polyene antifungal antibiotics on mammalian erythrocytes. Biochemical and Biophysical Research Communications 9, 503\u20137.","DOI":"10.1016\/0006-291X(62)90116-X"},{"key":"key\n\t\t\t\t20170411035151_R29","unstructured":"Brajtburg, J. & Bolard, J. 1996 Carrier effects on biological activity of amphotericin B. Clinical Microbiology Reviews 9, 512\u201331."},{"key":"key\n\t\t\t\t20170411035151_R30","doi-asserted-by":"crossref","unstructured":"Anaissie, E., Paetznick, V., Proffitt, R., Adler-Moore, J. & Bodey, G. P. 1991 Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. European Journal of Clinical Microbiology and Infectious Diseases 10, 665\u20138.","DOI":"10.1007\/BF01975823"},{"key":"key\n\t\t\t\t20170411035151_R31","doi-asserted-by":"crossref","unstructured":"Francis, P., Lee, J. W., Hoffman, A., Peter, J., Francesconi, A., Bacher, J. et al .1994 Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar d-mannitol and serum galactomannan as markers of infection. Journal of Infectious Diseases 169, 356\u201368.","DOI":"10.1093\/infdis\/169.2.356"},{"key":"key\n\t\t\t\t20170411035151_R32","doi-asserted-by":"crossref","unstructured":"Allende, M. C., Lee, J. W., Francis, P., Garrett, K., Dollenberg, J., Berenguer, J. et al.1994 Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis. Antimicrobial Agents and Chemotherapy 38, 518\u201322.","DOI":"10.1128\/AAC.38.3.518"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/43\/1\/95\/13056620\/JAC43195.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T18:46:58Z","timestamp":1512672418000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/43.1.95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1999,1]]},"published-print":{"date-parts":[[1999,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/43.1.95","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}